Artykuły w czasopismach na temat „Fibrosis”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Fibrosis”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
&NA;. "Cystic fibrosis and fibrosing colonopathy." Advances in Anatomic Pathology 3, no. 2 (1996): 112. http://dx.doi.org/10.1097/00125480-199603000-00015.
Pełny tekst źródłaSmyth, R. L. "Fibrosing colonopathy in cystic fibrosis." Archives of Disease in Childhood 74, no. 5 (1996): 464–68. http://dx.doi.org/10.1136/adc.74.5.464.
Pełny tekst źródłaEgea-Zorrilla, Alejandro, Zuri馿 Blasco-Iturri, Borja Saez, and Ana Pardo-Saganta. "The Notch3 Pathway in Organ Fibrosis." Fibrosis 2, no. 4 (2024): 10007. http://dx.doi.org/10.70322/fibrosis.2024.10007.
Pełny tekst źródłaMoreno Diaz, Claudia, Estrella Caballeria, and Jacobo Sellar閟 Torres. "Comparative Analysis of Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: Epidemiology, Pathophysiology, Clinical Features, Diagnosis and Treatment." Fibrosis 3, no. 1 (2025): 10001. https://doi.org/10.70322/fibrosis.2025.10001.
Pełny tekst źródłaCarrino, David A., Sam Mesiano, Nichole M. Barker, William W. Hurd, and Arnold I. Caplan. "Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition." Biochemical Journal 443, no. 2 (2012): 361–68. http://dx.doi.org/10.1042/bj20111996.
Pełny tekst źródłaKhan, Khaleque N., Akira Fujishita, Akemi Koshiba, et al. "Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas." PLOS ONE 15, no. 11 (2020): e0242246. http://dx.doi.org/10.1371/journal.pone.0242246.
Pełny tekst źródłaSferrazza, Sandro, Marcello Maida, Giulio Calabrese, et al. "The Derivation and External Validation of a Fibrosis Risk Model for Colorectal Tumours Undergoing Endoscopic Submucosal Dissection." Journal of Clinical Medicine 13, no. 15 (2024): 4517. http://dx.doi.org/10.3390/jcm13154517.
Pełny tekst źródłaPintér, István, Katalin Vágási, István Wittmann, and Judit Nagy. "Nephrogenic systemic fibrosis." Orvosi Hetilap 148, no. 38 (2007): 1801–4. http://dx.doi.org/10.1556/oh.2007.28183.
Pełny tekst źródłaSamokhodskaia, Larisa Mikhaylovna, Ekaterina Evgen'evna Starostina, Elena Borisovna Yarovaya, et al. "Mathematic Model for Prediction of Liver Fibrosis Progression Rate in Patients with Chronic Hepatitis C Based on Combination of Genomic Markers." Annals of the Russian academy of medical sciences 70, no. 6 (2015): 651–61. http://dx.doi.org/10.15690/vramn548.
Pełny tekst źródłaBertero, Michele, Serena Bainotti, Alberto Comino, et al. "Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis." European Journal of Dermatology 19, no. 1 (2009): 073–74. http://dx.doi.org/10.1684/ejd.2008.0547.
Pełny tekst źródładu Bois, R. M., and A. U. Wells. "Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis." European Respiratory Journal 18, no. 32 suppl (2001): 43S—55S. http://dx.doi.org/10.1183/09031936.01.18s320043.
Pełny tekst źródłaPrasad, Srinivasa R., and Jaishree Jagirdar. "Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy." Journal of Computer Assisted Tomography 32, no. 1 (2008): 1–3. http://dx.doi.org/10.1097/rct.0b013e31805d08ee.
Pełny tekst źródłaGalan, Anjela, Shawn E. Cowper, and Richard Bucala. "Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)." Current Opinion in Rheumatology 18, no. 6 (2006): 614–17. http://dx.doi.org/10.1097/01.bor.0000245725.94887.8d.
Pełny tekst źródłaFellrath, J. M., and R. M. du Bois. "Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis." Clinical and Experimental Medicine 3, no. 2 (2003): 65–83. http://dx.doi.org/10.1007/s10238-003-0010-3.
Pełny tekst źródłaMa, Hongge, Shupei Qiao, Zeli Wang, et al. "Microencapsulation of Lefty-secreting engineered cells for pulmonary fibrosis therapy in mice." American Journal of Physiology-Lung Cellular and Molecular Physiology 312, no. 5 (2017): L741—L747. http://dx.doi.org/10.1152/ajplung.00295.2016.
Pełny tekst źródłaHuang, Chenyu, and Rei Ogawa. "The Vascular Involvement in Soft Tissue Fibrosis—Lessons Learned from Pathological Scarring." International Journal of Molecular Sciences 21, no. 7 (2020): 2542. http://dx.doi.org/10.3390/ijms21072542.
Pełny tekst źródłaMasuzaki, Ryota, Tatsuo Kanda, Reina Sasaki, et al. "Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives." International Journal of Molecular Sciences 21, no. 14 (2020): 4906. http://dx.doi.org/10.3390/ijms21144906.
Pełny tekst źródłaLYON, IAN C. T., and DIANNE R. WEBSTER. "Newborn Screening for Cystic Fibrosis." Pediatrics 87, no. 6 (1991): 954–55. http://dx.doi.org/10.1542/peds.87.6.954.
Pełny tekst źródłaYu, Guoying. "Fibrosis: A New Open-Access Journal to Share Your Research." Fibrosis 1, no. 1 (2023): 1–2. http://dx.doi.org/10.35534/fibrosis.2023.10001.
Pełny tekst źródłaVijayakumar, Bavithra, and Pallav L. Shah. "Is Fibrosis Really Fibrosis?" American Journal of Respiratory and Critical Care Medicine 203, no. 11 (2021): 1440–42. http://dx.doi.org/10.1164/rccm.202102-0334le.
Pełny tekst źródłaD'Amico, A., V. Ficarra, A. Porcaro, et al. "L'eziopatogenesi della fibrosi retroperitoneale: Etiopathogenesis of retroperitoneal fibrosis." Urologia Journal 65, no. 2 (1998): 257–66. http://dx.doi.org/10.1177/039156039806500213.
Pełny tekst źródłaLi, Zhenwei, Zhao Zhu, Jiawei Wang, et al. "Exploring the Potential Relationship between Gut Microbiome Metabolites and Idiopathic Pulmonary Fibrosis via Network Pharmacology Study." Fibrosis 2, no. 4 (2024): 10009. http://dx.doi.org/10.70322/fibrosis.2024.10009.
Pełny tekst źródłaWang, Yanrong, Zuhao Li, Chenyang Zhang, Ziqi Jin, and Adam C. Midgley. "Dermal Fibrosis and the Current Scope of Hydrogel Strategies for Scarless Wound Healing." Fibrosis 2, no. 4 (2024): 10010. http://dx.doi.org/10.70322/fibrosis.2024.10010.
Pełny tekst źródłaArevalo, Carlo, and David J. Nagel. "Acute Exacerbations of Interstitial Lung Disease: Evolving Perspectives on Diagnosis and Management." Fibrosis 2, no. 4 (2024): 10008. http://dx.doi.org/10.70322/fibrosis.2024.10008.
Pełny tekst źródłaR. Lapthorn, Alice, Sophie L. Harding, Kieran M. Feltham, Deepika Sathyananth, Daniel C. Salisbury, and Selim Cellek. "A Review of the Current Landscape of Anti-Fibrotic Medicines." Fibrosis 2, no. 1 (2024): 10005. http://dx.doi.org/10.70322/fibrosis.2024.10005.
Pełny tekst źródłaJamalinia, Mohamad, Amedeo Lonardo, and Ralf Weiskirchen. "Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes." Fibrosis 2, no. 1 (2024): 10006. http://dx.doi.org/10.70322/fibrosis.2024.10006.
Pełny tekst źródłaWeiskirchen, Ralf, H鍁ard Attramadal, and Bernard Perbal. "12th International Workshop on the CCN Family of Genes." Fibrosis 2, no. 1 (2024): 10003. http://dx.doi.org/10.35534/fibrosis.2024.10003.
Pełny tekst źródłaGuo, Xiaoshu, Yue Zhang, Yingjie Wang, et al. "Mitochondrial Damage and Epithelial-Mesenchymal Transition as Major Triggers of the Development of Idiopathic Pulmonary Fibrosis." Fibrosis 2, no. 1 (2024): 10004. http://dx.doi.org/10.35534/fibrosis.2024.10004.
Pełny tekst źródłaVictorovich Garbuzenko, Dmitry. "Perspectives of Drug Therapy for Non-Alcoholic Steatohepatitis-Related Liver Fibrosis." Fibrosis 3, no. 1 (2025): 10002. https://doi.org/10.70322/fibrosis.2025.10002.
Pełny tekst źródłaTsomidis, Ioannis, George Notas, Argyro Voumvouraki, Dimitrios Samonakis, Mairi Koulentaki, and Elias Kouroumalis. "Hepatic Lysosomal Enzyme Activity in Primary Biliary Cholangitis." Fibrosis 1, no. 1 (2023): 1–12. http://dx.doi.org/10.35534/fibrosis.2023.10005.
Pełny tekst źródłaLi, Zhongzheng, Huabin Zhao, Shenghui Wang, et al. "Comprehensive Landscape of Matrix Metalloproteinases in the Pathogenesis of Idiopathic Pulmonary Fibrosis." Fibrosis 1, no. 1 (2023): 1–14. http://dx.doi.org/10.35534/fibrosis.2023.10004.
Pełny tekst źródłaDavid, Elroei, Alina Karabchevsky, Marina Wolfson, and Vadim E. Fraifeld. "Pulsed Ultraviolet C as a Potential Treatment for COVID-19." Fibrosis 1, no. 1 (2023): 1–6. http://dx.doi.org/10.35534/fibrosis.2023.10002.
Pełny tekst źródłaWeiskirchen, Ralf. "Established Hepatic Stellate Cell Lines in Hepatology Research." Fibrosis 1, no. 1 (2023): 1–9. http://dx.doi.org/10.35534/fibrosis.2023.10003.
Pełny tekst źródłaM. Artlett, Carol, and Lianne M. Connolly. "TANGO1 Dances to Export of Procollagen from the Endoplasmic Reticulum." Fibrosis 1, no. 2 (2023): 10008. http://dx.doi.org/10.35534/fibrosis.2023.10008.
Pełny tekst źródłaS. Espindola, Milena, David M. Habiel, Ana Lucia Coelho, et al. "Translational Studies Reveal the Divergent Effects of Simtuzumab Targeting LOXL2 in Idiopathic Pulmonary Fibrosis." Fibrosis 1, no. 2 (2023): 1–12. http://dx.doi.org/10.35534/fibrosis.2023.10007.
Pełny tekst źródłaWang, Chao, Amlan Chakraborty, Deidree V. N. Somanader, et al. "The Severity of Isoproterenol-induced Myocardial Fibrosis and Related Dysfunction in Mice is Strain-dependent." Fibrosis 1, no. 2 (2023): 1–9. http://dx.doi.org/10.35534/fibrosis.2023.10006.
Pełny tekst źródłaRius Rigau, Aleix, and Clara Dees. "Mechanisms of Fibroblast Activation during Fibrotic Tissue Remodeling." Fibrosis 2, no. 1 (2024): 10002. http://dx.doi.org/10.35534/fibrosis.2024.10002.
Pełny tekst źródłaLamas, Santiago, Katalin Susztak, and Fernando Rodr韌uez-Pascual. "The Cellular and Metabolic Bases of Organ Fibrosis: UNIA Workshop 2023 in Baeza, Spain." Fibrosis 2, no. 1 (2024): 10001. http://dx.doi.org/10.35534/fibrosis.2024.10001.
Pełny tekst źródłaWeiskirchen, Ralf, and Amedeo Lonardo. "Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction-Associated Steatohepatitis (MASH)." Fibrosis 3, no. 2 (2025): 10005. https://doi.org/10.70322/fibrosis.2025.10005.
Pełny tekst źródłaM. Sofroniou, Michael, та Christopher A. Lemmon. "Mechanics and Synergistic Signaling of Fibronectin, Integrins, and TGF-β Isoforms". Fibrosis 3, № 1 (2025): 10003–4. https://doi.org/10.70322/fibrosis.2025.10003.
Pełny tekst źródłaLiu, Hongli, Huachun Cui, and Gang Liu. "The Intersection between Immune System and Idiopathic Pulmonary Fibrosis—A Concise Review." Fibrosis 3, no. 1 (2025): 10004. https://doi.org/10.70322/fibrosis.2025.10004.
Pełny tekst źródłaM. McFalls, Caya, and Carol M. Artlett. "NLRP3 Inflammasome and IL-11 in Systemic Sclerosis Pulmonary Fibroblasts." Fibrosis 3, no. 2 (2025): 10006. https://doi.org/10.70322/fibrosis.2025.10006.
Pełny tekst źródłaCastellani, Carson, Gregory Capelli, and Bryan S. Benn. "Time Is Lung: Inpatient Transbronchial Lung Cryobiopsy Decreases Wait Time to Treatment Initiation for Newly Diagnosed Interstitial Lung Disease." Fibrosis 3, no. 2 (2025): 10007. https://doi.org/10.70322/fibrosis.2025.10007.
Pełny tekst źródłaPapiris, Spyros A., Panayiotis G. Vlachoyiannopoulos, Maria A. Maniati, Konstantinos X. Karakostas, Stavros H. Constantopoulos, and Haralampos H. Moutsopoulos. "Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis in Diffuse Systemic Sclerosis: Two Fibroses with Different Prognoses." Respiration 64, no. 1 (1997): 81–85. http://dx.doi.org/10.1159/000196648.
Pełny tekst źródłaChaturvedi, Rachana, Tejal Shah, Amita Joshi, Toshi Mishra, Manjusha Karegar, and Akash Shukla. "Histopathological Study of Non-Cirrhotic Portal Fibrosis (NCPF) With Special Emphasis on Advanced Fibrosis." Annals of Pathology and Laboratory Medicine 2, no. 12 (2018): A1002–1008. http://dx.doi.org/10.21276/apalm.2358.
Pełny tekst źródłaPrakash, Sadhana, Amin A. Nanji, and Phillips W. Robbins. "Fibrosin: A Novel Lymphokine in Alcohol-Induced Fibrosis." Experimental and Molecular Pathology 67, no. 1 (1999): 40–49. http://dx.doi.org/10.1006/exmp.1999.2274.
Pełny tekst źródłaBrett, Allan S., and Elizabeth H. Mack. "Fibrosing Colonpathy in Adults with Cystic Fibrosis." American Journal of Roentgenology 190, no. 1 (2008): W73. http://dx.doi.org/10.2214/ajr.06.1589.
Pełny tekst źródłaSchwarzenberg, S. J., C. L. Wielinski, I. Shamieh, et al. "Cystic fibrosis–associated colitis and fibrosing colonopathy." Journal of Pediatrics 127, no. 4 (1995): 565–70. http://dx.doi.org/10.1016/s0022-3476(95)70113-3.
Pełny tekst źródłaLittlewood, J. M. "Fibrosing colonopathy in children with cystic fibrosis." Postgraduate Medical Journal 72, no. 845 (1996): 129–30. http://dx.doi.org/10.1136/pgmj.72.845.129.
Pełny tekst źródłaReichard, Kirk W., Charles D. Vinocur, Maria Franco, et al. "Fibrosing colonopathy in children with cystic fibrosis." Journal of Pediatric Surgery 32, no. 2 (1997): 237–42. http://dx.doi.org/10.1016/s0022-3468(97)90186-x.
Pełny tekst źródła